Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tribal Therapeutics
Cambridge, Massachusetts, United Statestribaltx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Tribal Therapeutics is a Cambridge-based biotechnology company focused on discovering and developing novel therapeutics by leveraging the unique genetic insights of founder populations. Founded by former Merck R&D chief Peter Kim and backed by Atlas Venture, the company utilizes a platform that identifies rare genetic variants with large phenotypic effects to uncover high-conviction drug targets. Tribal's approach aims to translate these genetic discoveries into precision medicines for a range of indications, including metabolic and cardiovascular diseases. The company operates in the pre-clinical stage, focusing on target validation and early-stage drug discovery.
- Therapeutic areas
- CardiovascularMetabolic Disorders
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on Tribal Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tribal Therapeutics.